Patents by Inventor Helen Waldschmidt

Helen Waldschmidt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10329283
    Abstract: Disclosed herein are novel GRK inhibitors and methods for their use in treating or preventing heart disease, such as cardiac failure, cardiac hypertrophy, and hypertension. In particular, disclosed herein are compounds of Formula (I) and pharmaceutically acceptable salt thereof, wherein the substituents are as described.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: June 25, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Scott D. Larsen, John J. G. Tesmer, Helen Waldschmidt, Kristoff Homan, Michael William Wilson
  • Patent number: 10023564
    Abstract: Disclosed herein are novel GRK2 inhibitors and methods for their use in treating or preventing heart disease, such as cardiac failure, cardiac hypertrophy, and hypertension. In particular, disclosed herein are compounds of Formula (I) and pharmaceutically acceptable salt thereof: wherein the substituents are as described.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: July 17, 2018
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Scott D. Larsen, Kristoff Homan, Helen Waldschmidt, John J. G. Tesmer
  • Publication number: 20180186779
    Abstract: Disclosed herein are novel GRK inhibitors and methods for their use in treating or preventing heart disease, such as cardiac failure, cardiac hypertrophy, and hypertension. In particular, disclosed herein are compounds of Formula (I) and pharmaceutically acceptable salt thereof, wherein the substituents are as described.
    Type: Application
    Filed: June 27, 2016
    Publication date: July 5, 2018
    Inventors: Scott D. Larsen, John J.G. Tesmer, Helen Waldschmidt, Kristoff Homan, Michael William Wilson
  • Publication number: 20170240538
    Abstract: Disclosed herein are novel GRK2 inhibitors and methods for their use in treating or preventing heart disease, such as cardiac failure, cardiac hypertrophy, and hypertension. In particular, disclosed herein are compounds of Formula (I) and pharmaceutically acceptable salt thereof: wherein the substituents are as described.
    Type: Application
    Filed: August 10, 2015
    Publication date: August 24, 2017
    Inventors: Scott D. Larsen, Kristoff Homan, Helen Waldschmidt, John J.G. Tesmer